News & Events
Feb 4, 2019
CathWorks Announces Completion Of $30 Million Financing.
CathWorks announced the completion of a $30 million Series C financing round led by Deerfield Management.
Dec 20, 2018
CathWorks FFRangio™ System Receives U.S. FDA Clearance.
CathWorks announced today that its FFRangio™ System received United States Food & Drug Administration (FDA) 510(k) clearance. The FFRangio system demonstrated accuracy versus the invasive FFR wire in a blinded comparative study, FAST-FFR.
Sep 24, 2018 – San Diego, CA
Lunch Presentation Theater Program
FFRangio for PCI Guidance:
A Clinical Review